IPO Year: 2020
Exchange: NYSE
| Date | Price Target | Rating | Analyst |
|---|
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
3 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
424B3 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)
424B3 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)
8-K - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)
8-K - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)
424B3 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)
424B3 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)
8-K - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)
8-K - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)
424B3 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)
EFFECT - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)
Fastest customizable press release news feed in the world
NASHVILLE, Tenn. & PALO ALTO, Calif.--(BUSINESS WIRE)--Clover Health Investments, Corp. (“Clover”), an innovative technology company improving health outcomes for America's seniors, and Social Capital Hedosophia Holdings Corp. III (NYSE: IPOC) ("SCH"), a publicly traded special purpose acquisition company, today completed their previously announced business combination to form one of the nation’s fastest growing publicly-traded Medicare Advantage insurers. The newly formed company is named Clover Health Investments, Corp. (“Clover Health” or the “Company”) and its shares of Class A common stock and warrants will start trading on The Nasdaq Global Select Market (“Nasdaq”) under the n
PALO ALTO, Calif.--(BUSINESS WIRE)--Social Capital Hedosophia Holdings Corp. III (NYSE: IPOC) (“SCH” and, after the Domestication and business combination as described below, “Clover Health”), a publicly traded special purpose acquisition company, announced today that in an extraordinary general meeting on January 6, 2021, its shareholders voted to approve its proposed business combination (the “business combination”) with Clover Health Investments, Corp. (“Clover”). Approximately 99.5% of the votes cast at the meeting, representing approximately 65.0% of SCH’s outstanding shares, voted to approve the business combination. The business combination is expected to close on January 7,
This live feed shows all institutional transactions in real time.
SC 13G/A - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Subject)
SC 13G - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Subject)
SC 13G/A - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Subject)